Portland, OR, Sept. 14, 2021 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Pneumonia Therapeutics Market generated $12.2 billion in 2020, and is projected to reach $25.5 billion by 2030, witnessing a CAGR of 8.5% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11595
Surge in prevalence of pneumonia, rise in geriatric population with weaker immune systems, increase in incidence and spending for community-acquired pneumonia, and rise in number of product launches drive the growth of the global pneumonia therapeutics market. However, high price of pneumonia therapeutics restrains the market to some extent. On the other hand, outbreak of novel viruses attacking respiratory system presents new opportunities in the upcoming years.
- The outbreak of the COVID-19 pandemic has positively impacted the pneumonia therapeutics market, owing to declaration by WHO that people suffering from COVID-19 is highly susceptible to pneumonia.
- Moreover, surge in R&D for the treatment of COVID-19 associated pneumonia has generated high revenue.
- However, dearth of workforce as well as resource limitations due to COVID-19 are expected to negatively impact the growth of the industry in the forecast period.
The report offers detailed segmentation of the global pneumonia therapeutics market based on therapeutics, distribution channel, age group, and region.
Based on therapeutics, the prevention vaccines segment held the highest market share in 2020, holding more than two-thirds of the total market share, and is expected to continue its leadership status during the forecast period. However, the treatment drugs segment is estimated to register the highest CAGR of 9.6% from 2021 to 2030.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11595
Based on distribution channel, the hospitals segment held the largest market share in 2020, holding more than three-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the pharmaceutical stores segment is projected to register the highest CAGR of 10.0% from 2021 to 2030.
Based on region, North America contributed to the highest share in terms of revenue in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, LAMEA is projected to manifest the fastest CAGR of 12.0% during the forecast period.
Leading players of the global pneumonia therapeutics market analyzed in the research include Abbott Laboratories, Bayer AG, Eli Lilly & Company, Glaxosmithkline PLC., Lupin Pharmaceuticals, Inc., Merck KGAA, Novartis AG, Pfizer, Inc., Sanofi S.A., and Teva Pharmaceuticals Industries Limited.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.